Allogeneic bone marrow transplantation for chronic myeloid leukemia using sibling and volunteer unrelated donors. A comparison of complications in the first 2 years.
about
Hospital capacity and post-transplant survival after allogeneic bone marrow transplantation: analysis of data from the Japan Society for Hematopoietic Cell Transplantation.Increased incidence of neurological complications in patients receiving an allogenic bone marrow transplantation from alternative donors.Clinical grading in chronic graft-versus-host disease: is it time for change?Successful matched unrelated transplantation from a donor with idiopathic thrombocytopenic purpura (ITP).Unrelated donor bone marrow transplantation in adults: some current controversies.Molecular matching in allogeneic bone marrow transplantation.Haemopoietic stem cell transplantation from unrelated donors.Benign and malignant neoplasms of the periodontium.Reduced plasma levels of soluble interleukin-7 receptor during graft-versus-host disease (GVHD) in children and adults.Chronic myelogenous leukaemia.Outcome and clinical course of 100 patients with adenovirus infection following bone marrow transplantation.Reactivation of human herpesviruses after allogeneic peripheral blood stem cell transplantation and bone marrow transplantation.Unrelated donor hematopoietic transplantation.Use of matched unrelated donors compared with matched related donors is associated with lower relapse and superior progression-free survival after reduced-intensity conditioning hematopoietic stem cell transplantationTissue typing in support of unrelated hematopoietic cell transplantation.Nonmyeloablative allogeneic stem cell transplantation using alternative donors.Antilymphocyte/thymocyte globulin for graft versus host disease prophylaxis: efficacy and side effects.IL-7 enhances peripheral T cell reconstitution after allogeneic hematopoietic stem cell transplantation.Comparable outcomes after nonmyeloablative hematopoietic cell transplantation with unrelated and related donors.Preparations for unrelated donor transplantation.Hydrodynamic delivery of human IL-15 cDNA increases murine natural killer cell recovery after syngeneic bone marrow transplantationCellular therapies in acute lymphoblastic leukemiaHaving a child to save a sibling: reassessing risks and benefits of creating stem cell donors.The graft-versus-leukemia effect using matched unrelated donors is not superior to HLA-identical siblings for hematopoietic stem cell transplantation.Immunohistochemical changes in sigmoid colon after allogeneic and autologous bone marrow transplantation.The effect of smoking on allogeneic transplant outcomes.Antithymocyte globulin for acute-graft-versus-host-disease prophylaxis in patients undergoing allogeneic hematopoietic cell transplantation: a systematic review.Recent Advances in Bone Marrow Transplantation from Unrelated Volunteer Donors.Options for therapy in chronic myeloid leukaemia.Gram-negative bacteraemia (GNB) after 428 unrelated donor bone marrow transplants (UD-BMT): risk factors, prophylaxis, therapy and outcome.Factors affecting reconstitution of the T cell compartment in allogeneic haematopoietic cell transplant recipients.Early infections in adult patients undergoing unrelated donor cord blood transplantation.Early infections in adults undergoing matched related and matched unrelated/mismatched donor stem cell transplantation: a comparison of incidence.Bone marrow transplantation using unrelated donors for haematological malignancies.Multi-unit anti-BCR-ABL ribozyme therapy in chronic myelogenous leukemia.Late infections following allogeneic bone marrow transplantation: suggested strategies for prophylaxis.Factors influencing the outcome of bone marrow transplants using unrelated donors.Adoptive cellular immunotherapy for EBV lymphoproliferative disease.Allogeneic bone marrow transplantation for hematological malignancies--controversies and recent advances.Increased costs after allogeneic haematopoietic SCT are associated with major complications and re-transplantation.
P2860
Q30620615-BD5EF420-6C44-473D-ABF7-33F7671F3CCDQ33179317-1F8D1258-18C1-49BE-9520-FCB2562878F8Q33343489-62E84D22-C71A-4165-9856-CED4DEF3FAF1Q33495061-9A311636-5651-4C74-BA90-01A72D9DD6ECQ33536887-7690B6E6-DCD8-41BC-A074-1474FC944652Q33539331-A9FDB361-AC54-4DFB-86CE-FDC3C77B719DQ33656177-4C89B0B9-4FEC-4057-A75B-FD00F5494C2DQ33768613-A24B24C0-FBA9-4DFB-8C28-C30167041859Q33817588-4AE91A5A-5471-4B8B-A907-A328D8FCB3DAQ34135279-4F2A5841-456E-49AA-9D4B-BE8C001A455EQ34165176-3FD93AA9-1BCC-4CF3-A334-C7391867A84AQ34244404-3FCCA9C9-6738-4850-8AC9-7CA5AB0B7EF8Q34326698-A5192D76-87DD-4E3B-BDE1-05EC07A3E17FQ34827332-AF2D7504-B4B3-4277-AA43-2596DC4EC91BQ35080070-94DD2D7D-9021-4476-B067-173744553C78Q35692616-C1A81606-0E0E-4F1A-8CA6-CBDD0F129480Q35959473-4FC1B8F6-59A4-4CFC-87A5-C2EE7A91C8AAQ36001183-CDC0D522-E233-4DB5-A152-5C113AD3293BQ36320260-98F3A1A2-B7A4-4692-9269-35471BA6D59FQ36362050-23B9A908-18D6-4824-A06D-FD7B855A09F3Q36423437-83A827AD-0337-492A-99CD-C12489BCD54AQ36552098-83CEADD1-4D07-40BF-B8C0-529BD544F935Q36569483-22E6646C-9E9A-4DAE-A6F2-91F82434FA9EQ37143670-2098F005-8BB9-4A53-BCC6-96EACD4B55A6Q37260162-4AA06D16-A167-4B2D-8A5D-8921D84BE596Q37401674-3BB98A03-AE94-4A7B-8FC8-98B944CF7EB0Q37969888-5A171D2D-C115-4A4B-AA68-26EE84B99FB9Q38894371-CEABC282-3EA6-4966-BA7D-E52467A8AF5BQ40424271-13FD12CD-2490-4FDC-8EAC-B51287EF7420Q40545180-BB7082A7-ADAB-4B4B-B411-7F6D3F37D797Q40552200-8E0F07DF-10D6-4F32-A3DD-5ECBCA9A47F1Q40569370-0E516D4B-3D34-4CBC-B273-4C7300E1AF87Q40575644-008FC33D-B661-455C-B07B-C4C018409F1FQ40901324-E3F11ABA-EB38-4875-B2E1-2BBE1E6F12A4Q41177593-E7B50673-A651-42AC-9235-DA1125507BEDQ41557335-87B01A88-EA8B-4A4D-AB0E-901C4AB3861AQ41561723-8CCA79E0-2336-45AA-B978-9163424B8021Q41561751-D1C230C2-4352-4BC0-9364-8593FC46B217Q41668011-4ADE8DC7-AECD-43BD-87DC-15460E7FB32EQ43430861-4A4A9563-D185-4ED7-B30A-B39F7D82BEF7
P2860
Allogeneic bone marrow transplantation for chronic myeloid leukemia using sibling and volunteer unrelated donors. A comparison of complications in the first 2 years.
description
1993 nî lūn-bûn
@nan
1993年の論文
@ja
1993年論文
@yue
1993年論文
@zh-hant
1993年論文
@zh-hk
1993年論文
@zh-mo
1993年論文
@zh-tw
1993年论文
@wuu
1993年论文
@zh
1993年论文
@zh-cn
name
Allogeneic bone marrow transpl ...... ications in the first 2 years.
@en
type
label
Allogeneic bone marrow transpl ...... ications in the first 2 years.
@en
prefLabel
Allogeneic bone marrow transpl ...... ications in the first 2 years.
@en
P2093
P1476
Allogeneic bone marrow transpl ...... ications in the first 2 years.
@en
P2093
Barrett AJ
Batchelor JR
Goldman JM
Schwarer AP
P304
P356
10.7326/0003-4819-119-3-199308010-00005
P407
P577
1993-08-01T00:00:00Z